Publications by authors named "Mark Carfagna"

Claim this Profile
A
A Phase-Appropriate Risk Assessment Strategy in Support of the Safety of Peptide and Oligonucleotide-Related Impurities.
Brian W Pack, Robert W Siegel, Paul D Cornwell, Andrea Ferrante, Douglas A Roepke, Mark A Carfagna

AAPS J· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cross study analyses of SEND data: toxicity profile classification.
Mark A Carfagna, Cm Sabbir Ahmed, Susan Butler, Tamio Fukushima, William Houser

Toxicol Sci· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Leveraging the Value of CDISC SEND Data Sets for Cross-Study Analysis: Incidence of Microscopic Findings in Control Animals.
Mark A Carfagna, Jesse Anderson, Christopher Eley, Tamio Fukushima, Joseph Horvath

Chem Res Toxicol· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SEND harmonization & cross-study analysis: A proposal to better harvest the value from SEND data.
Mark A Carfagna, Thomas G Bjerregaard, Tamio Fukushima, William Houser, Cheryl Sloan

Regul Toxicol Pharmacol· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Carcinogenicity assessment of baricitinib in Tg.rasH2 mice and Sprague-Dawley (Crl:CD) rats.
Mark Carfagna, Ellen Cannady, Thomas Ryan, Jay Herman, Lew Truex

Regul Toxicol Pharmacol· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Withdrawal assessment following subchronic oral ketamine administration in Cynomolgus macaques.
Jennie L Walgren, Mark A Carfagna, Deanna Koger, Mario Sgro, Mary Jeanne Kallman

Drug Dev Res· May 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biological characterization of a heterodimer-selective retinoid X receptor modulator: potential benefits for the treatment of type 2 diabetes.
Mark D Leibowitz, Robert J Ardecky, Marcus F Boehm, Carol L Broderick, Mark A Carfagna

Endocrinology· February 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Involvement of calcium channels in the sexual dimorphism of cadmium-induced hepatotoxicity.
Thomas K Baker, Heidi B VanVooren, Wendell C Smith, Mark A Carfagna

Toxicol Lett· February 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis